These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 600961

  • 1. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW, Brickman AS, Sherrard DJ, Singer FR, Wong EG, Baylink DJ, Norman AW.
    Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
    [Abstract] [Full Text] [Related]

  • 2. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H.
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [Abstract] [Full Text] [Related]

  • 3. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A.
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [Abstract] [Full Text] [Related]

  • 4. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
    Pierides AM, Skillen AW, Ellis HA.
    J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
    [Abstract] [Full Text] [Related]

  • 5. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
    Pierides AM, Ellis HA, Simpson W, Cook D, Kerr DN.
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N, Catto GR, Edward N, Fraser RA, O'Riordan JL, Papapoulos SE, Adami S.
    Proc Eur Dial Transplant Assoc; 1980 Dec; 17():543-7. PubMed ID: 6972529
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 8. 1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.
    Fournier AE, Bordier PJ, Gueris J, Chanard J, Marie P, Ferriere C, Osario M, Bedrossian J, de Luca HF.
    Proc Eur Dial Transplant Assoc; 1976 Feb; 12():227-36. PubMed ID: 935115
    [Abstract] [Full Text] [Related]

  • 9. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
    Moorthy AV, Harrington AR, Mazess RB, Simpson DP.
    Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893
    [Abstract] [Full Text] [Related]

  • 10. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G, Schaefer K, Schulz A, Delling G.
    Klin Wochenschr; 1976 Jul 01; 54(13):625-32. PubMed ID: 940299
    [Abstract] [Full Text] [Related]

  • 11. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL, Brownjohn AM, Goodwin FJ, Hately W, Manning RM, O'Riordan JH, Papapoulos SE, Marsh FP.
    Q J Med; 1982 Jul 01; 51(203):271-8. PubMed ID: 7146311
    [Abstract] [Full Text] [Related]

  • 12. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G.
    Clin Nephrol; 1984 Dec 01; 22(6):279-83. PubMed ID: 6525771
    [Abstract] [Full Text] [Related]

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 14. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL, Felsenfeld AJ, Llach F.
    Arch Intern Med; 1983 Jun 01; 143(6):1205-11. PubMed ID: 6344827
    [Abstract] [Full Text] [Related]

  • 15. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T, Berns AS, Hufer WE, Hammill K, Alfrey AC, Arnaud CD, Schrier RW.
    Ann Intern Med; 1978 Jun 01; 88(6):774-80. PubMed ID: 208439
    [Abstract] [Full Text] [Related]

  • 16. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
    Massry SG, Goldstein DA, Malluche HH.
    Kidney Int; 1980 Oct 01; 18(4):409-18. PubMed ID: 7014981
    [No Abstract] [Full Text] [Related]

  • 17. Comparative therapeutic effects of vitamin D3 and its derivatives on experimental renal osteodystrophy.
    Fukushima M, Niki R, Ohkawa H, Shimizu T, Matsunaga I, Nakano H, Takagaki Y, Nishii Y, Okano K, Suda T.
    Endocrinology; 1980 Jul 01; 107(1):328-33. PubMed ID: 6247140
    [Abstract] [Full Text] [Related]

  • 18. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb 01; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Ferrière C, Bedrossian J, DeLuca HF.
    Kidney Int; 1979 Feb 01; 15(2):196-204. PubMed ID: 513484
    [No Abstract] [Full Text] [Related]

  • 20. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
    Jablonski G, Klem KH, Attramadal A, Dahl E, Rønningen H, Gautvik KM, Haug E, Gordeladze JO.
    Biosci Rep; 1993 Oct 01; 13(5):275-87. PubMed ID: 8142613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.